FDA considers expanded use of HPV vaccine

Mar 20, 2008

Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.

Merck said the FDA has agreed to conduct a priority review of Merck's application to expand the current approved usage of Gardasil -- a vaccine used to prevent infection by the human papillomavirus, or HPV -- from children and women ages 9-26 to women ages 27 through 45.

The pharmaceutical company said Gardasil is used to prevent cervical cancer, precancerous or dysplastic lesions and genital warts caused by HPV.

Gardasil, sold in some countries as Silgard, has been approved in 100 nations, including the United States, the European Union, Mexico, Australia, Taiwan, Canada, New Zealand and Brazil, Merck said.

Copyright 2008 by United Press International

Explore further: High radiotherapy dose improves prospects for children with brain cancer

Related Stories

European physicist discusses Higgs boson at Brown University

3 hours ago

The head of the European Organization for Nuclear Research says the historic 2012 discovery of the Higgs boson particle and the particle accelerator that detected it are getting scientists closer to understanding the creation ...

IBM earnings dip as sales fall again

3 hours ago

Technology heavyweight IBM reported Monday lower profits in the first quarter following another drop in revenues, this time partly due to the strong dollar.

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

herpesdate
not rated yet Apr 03, 2008
HPV vaccine is useful and some HpV user at www.STDRomance.com use it

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.